Two Experimental Ebola Vaccines Pass Safety Test in African Trial

Reuters – Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, "appear to be safe" part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health (NIH) said on Thursday.

More from Black Report:

  • January 5, 2017 ‘Black Fashion Designers’ In The Spotlight At FIT The Villager - Celebrating style mavens of African descent and their contributions to fashion from the 1950s to the present, “Black Fashion Designers” is a notable […]
  • February 2, 2017 How Blacks Took Banking Into Their Own Hands USA Today - More than 18% of African Americans don’t have traditional bank accounts, compared with 7% of all Americans, according to the Federal Deposit Insurance […]
  • October 9, 2013 Hope for malaria vaccine by 2015 BBC News - British drug maker GlaxoSmithKline is seeking regulatory approval for the world's first malaria vaccine after trial data showed that it had cut the […]
  • March 12, 2015 U.N.: Ebola Deaths Surpass 10,000, Most in West Africa USA Today - The World Health Organization marked a grim milestone Thursday in the biggest-ever Ebola outbreak, estimating that the virus had killed over 10,000 […]